Product Description
- The Finecare cTn I Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare FIA System for quantitative determination of cardiac troponin I (cTn I) in human whole blood, serum or plasma. This test is used as an aid to assist in the diagnosis of acute myocardial infarction (AMI).
- STORAGE AND STABILITY1. Store the test kit at 430 up to the expiration date printed on package.
2. If removed from refrigerator, allow the test kit for 30 minutes to return to room temperature before testing.
3. Do not remove the Test Cartridge from the pouch until use. The Test Cartridge should be used within 1 hour once opened.
Technical Details 
Fast and Accurate Heart Attack DiagnosisFinecare CTn I provides results within 15 minutes, enabling prompt clinical intervention for suspected myocardial infarction cases. Its high sensitivity and specificity make it reliable for detecting cTnI even at low concentrations (LOD: 0.1 ng/mL), boosting diagnostic confidence. The test is ideal for emergency settings, ensuring patient care is prioritized without delay.
Simple Workflow and Easy InterpretationThe test is designed for seamless use by laboratory professionals and emergency staff. Requiring just 80 L of sample, it operates at room temperature and is compatible with Finecare FIA analyzers. Its portable design ensures it can be deployed wherever quick diagnostic support is needed, with results interpreted quantitatively via the connected analyzer.
Safe, Reliable, and Convenient PackagingEach kit contains 25 individually packed test cassettes, ensuring single-use convenience and hygiene. Lot numbers and expiry dates are clearly marked for quality control. Proper disposal as biohazard waste is recommended, and the compact size allows easy storage in clinical settings, with a shelf life of 18-24 months.
FAQ's of Finecare CTn I Rapid Quantitative Test:
Q: How does the Finecare CTn I Rapid Quantitative Test detect a heart attack?
A: This test measures the concentration of cardiac troponin I (cTnI) in whole blood, serum, or plasma using fluorescence immunoassay technology. Elevated cTnI levels indicate myocardial cell injury, which helps confirm or rule out a heart attack.
Q: What is the process for using the Finecare CTn I test in clinical settings?
A: Collect 80 L of patient sample (whole blood, serum, or plasma), apply it to the cassette, and insert the cassette into the Finecare FIA Meter/Analyzer. The instrument automatically reads and displays the quantitative result in about 15 minutes.
Q: When should laboratory professionals choose this test for patient evaluation?
A: This test should be used when prompt diagnosis of myocardial infarction is crucial, especially in emergency units or situations where fast, reliable results are imperative for patient management.
Q: Where should the test kits be stored to maintain accuracy?
A: Store the test kits in a dry place at 2-30C, avoiding direct sunlight and keeping humidity below 80% RH. Adhering to these conditions ensures optimal test performance and shelf life.
Q: What are the benefits of using Finecare CTn I test over conventional diagnostic methods?
A: It offers rapid, quantitative results with accuracy above 95%, high sensitivity, and specificity, requiring minimal sample volume. The device is portable and easy to use, making it particularly useful for urgent, point-of-care situations.
Q: How is the test result interpreted and displayed?
A: Results are read quantitatively using the Finecare FIA Meter/Analyzer. The analyzer provides precise cTnI concentration values, helping clinicians make informed diagnostic decisions.
Q: What should be done with used test cassettes?
A: Dispose of used cassettes as biohazard waste according to clinical waste protocols to ensure safety and environmental compliance.